Short answer · Medically reviewed summary · Last updated: 2023-07-13
SAPHO syndrome is a rare condition characterized by a combination of skin, bone, and joint manifestations. Due to its rarity, the prevalence of SAPHO syndrome is not well-established.
What is the prevalence of SAPHO syndrome?
Prevalence of SAPHO syndrome: how many people are affected worldwide, differences by sex and region, with sources.
SAPHO syndrome is a rare condition characterized by a combination of skin, bone, and joint manifestations. Due to its rarity, the prevalence of SAPHO syndrome is not well-established. However, it is estimated to affect approximately 1 in 10,000 to 1 in 40,000 individuals.
The acronym SAPHO stands for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis, which are the key features of this syndrome. It typically presents in adulthood, with a slight female predominance.
The exact cause of SAPHO syndrome remains unknown, but it is believed to involve a combination of genetic, immunological, and environmental factors. The symptoms can vary widely among individuals, making diagnosis challenging.
Treatment for SAPHO syndrome focuses on managing the symptoms and may involve a multidisciplinary approach. Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) are commonly used to alleviate pain and inflammation.
While SAPHO syndrome is a rare condition, raising awareness among healthcare professionals is crucial for early recognition and appropriate management.
